The Pharmacology Center

Filter Your Results




Abbott Vascular's XIENCE 28 GLOBAL Trial Enrolls First Patient in Europe

February 12, 2018 -- Abbott Vascular announced the first patient has been enrolled in XIENCE 28 GLOBAL, a clinical trial evaluating whether patients at high risk of bleeding c…

FDA Seeks to Strengthen Public Warnings and Recall Notifications; CDRH Outlines Strategic Priorities

January 18, 2018 -- US Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, issued a statement on the agency's new policy steps for strengthening public war…

One-Year Outcomes From PRAGUE-18 Trial Compare Prasugrel and Ticagrelor

January 22, 2018 -- One-year outcomes from the PRAGUE-18 trial, a comparison of prasugrel and ticagrelor for the treatment of acute myocardial infarction (MI), were published …

Findings Published From PRESTIGE Registry Evaluating High Platelet Reactivity

December 21, 2017 -- Results from the PRESTIGE registry were published by Thea C. Godschalk, MSc, et al in Journal of the American College of Cardiology (JACC): Cardiovascular…

Janssen Seeks New Indications for Xarelto for Patients With Chronic CAD or PAD

December 11, 2017 -- Janssen Research & Development, LLC announced that it has submitted a supplemental New Drug Application to the US Food and Drug Administration for two…

FDA Approves Amgen’s Repatha for Prevention of Heart Attack and Stroke

December 1, 2017 -- Amgen announced that after priority review of its supplemental Biologics License Application, the US Food and Drug Administration (FDA) approved Repatha (e…

PhaseBio Enters Worldwide License Agreement With MedImmune for a Reversal Agent for Ticagrelor

November 28, 2017 -- PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing therapies for the treatment of orphan diseases, announced that the c…

Study Compares DAPT Durations in STEMI Patients Receiving DES

November 1, 2017 -- Results from the DAPT STEMI were reported at TCT 2017, the 29th annual Transcatheter Cardiovascular Therapeutics scientific symposium being held October 30…



2018 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.